These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 14660102

  • 1. Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections.
    Bismar TA, Bianco FJ, Zhang H, Li X, Sarkar FH, Sakr WA, Grignon DJ, Che M.
    Pathology; 2003 Dec; 35(6):513-7. PubMed ID: 14660102
    [Abstract] [Full Text] [Related]

  • 2. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT, Tu JJ, Kao J, Zhou XK, Mazumdar M.
    Clin Cancer Res; 2005 Sep 15; 11(18):6558-66. PubMed ID: 16166433
    [Abstract] [Full Text] [Related]

  • 3. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.
    Uemura H, Nakagawa Y, Yoshida K, Saga S, Yoshikawa K, Hirao Y, Oosterwijk E.
    Br J Cancer; 1999 Oct 15; 81(4):741-6. PubMed ID: 10574265
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
    Gupta R, Balzer B, Picken M, Osunkoya AO, Shet T, Alsabeh R, Luthringer D, Paner GP, Amin MB.
    Am J Surg Pathol; 2009 Feb 15; 33(2):241-7. PubMed ID: 18941400
    [Abstract] [Full Text] [Related]

  • 5. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M.
    Dan Med J; 2017 Oct 15; 64(10):. PubMed ID: 28975890
    [Abstract] [Full Text] [Related]

  • 6. Real-time quantitative reverse transcription-PCR assay for renal cell carcinoma-associated antigen G250.
    Chuanzhong Y, Ming G, Fanglin Z, Haijiao C, Zhen L, Shiping C, YongKang Z.
    Clin Chim Acta; 2002 Apr 15; 318(1-2):33-40. PubMed ID: 11880110
    [Abstract] [Full Text] [Related]

  • 7. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
    Yao M, Tabuchi H, Nagashima Y, Baba M, Nakaigawa N, Ishiguro H, Hamada K, Inayama Y, Kishida T, Hattori K, Yamada-Okabe H, Kubota Y.
    J Pathol; 2005 Feb 15; 205(3):377-87. PubMed ID: 15682440
    [Abstract] [Full Text] [Related]

  • 8. The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.
    Li G, Passebosc-Faure K, Lambert C, Gentil-Perret A, Blanc F, Oosterwijk E, Mosnier JF, Genin C, Tostain J.
    Clin Cancer Res; 2001 Jan 15; 7(1):89-92. PubMed ID: 11205923
    [Abstract] [Full Text] [Related]

  • 9. [Detection of carbonic anhydrase IX gene expression in renal cell carcinoma with reverse transcription-PCR].
    Jiang YD, Zheng SB, Wang ZH.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan 15; 24(1):99-101. PubMed ID: 14724112
    [Abstract] [Full Text] [Related]

  • 10. [MN/CA IX antigen as a potential target for renal cell carcinoma].
    Uemura H, Cho M, Nakagawa Y, Shimizu K, Yoshikawa M, Kim S, Hirao Y.
    Hinyokika Kiyo; 2000 Oct 15; 46(10):745-8. PubMed ID: 11215204
    [Abstract] [Full Text] [Related]

  • 11. Detection of circulating MN/CA9 positive renal cell carcinoma cells during operation.
    Uemura H, Nakagawa Y, Iwai A, Okajima E, Okajima E, Yoshikawa K, Hirao Y.
    Aktuelle Urol; 2003 Jul 15; 34(4):270-2. PubMed ID: 14566683
    [Abstract] [Full Text] [Related]

  • 12. Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma.
    Grabmaier K, A de Weijert MC, Verhaegh GW, Schalken JA, Oosterwijk E.
    Oncogene; 2004 Jul 22; 23(33):5624-31. PubMed ID: 15184875
    [Abstract] [Full Text] [Related]

  • 13. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
    Liao SY, Aurelio ON, Jan K, Zavada J, Stanbridge EJ.
    Cancer Res; 1997 Jul 15; 57(14):2827-31. PubMed ID: 9230182
    [Abstract] [Full Text] [Related]

  • 14. [Molecular detection of circulating cancer cells in patients with renal cell carcinoma].
    Uemura H.
    Hinyokika Kiyo; 1999 Aug 15; 45(8):571-5. PubMed ID: 10500965
    [Abstract] [Full Text] [Related]

  • 15. [Value of MN/CAIX in the diagnosis of renal cell carcinoma].
    Jiang YD, Ren F, Zheng SB.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar 15; 32(3):412-4. PubMed ID: 22445996
    [Abstract] [Full Text] [Related]

  • 16. [MN/CAIX gene expression in renal cell carcinoma detected by RT-PCR].
    Jiang YD, Zheng SB, Wang ZH.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug 15; 24(8):925-7. PubMed ID: 15321764
    [Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS.
    Clin Cancer Res; 2003 Feb 15; 9(2):802-11. PubMed ID: 12576453
    [Abstract] [Full Text] [Related]

  • 18. Detection of circulating tumor cells in patients with renal cell carcinoma by reverse transcriptase polymerase chain reaction for G250/MNCA-9: results of a prospective trial.
    Ohlmann CH, Ozgür E, Schrader AJ, Konrad L, Hofmann R, Engelmann U, Heidenreich A.
    Urol Oncol; 2006 Feb 15; 24(4):287-93. PubMed ID: 16818180
    [Abstract] [Full Text] [Related]

  • 19. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ.
    Hum Pathol; 2005 Mar 15; 36(3):262-8. PubMed ID: 15791570
    [Abstract] [Full Text] [Related]

  • 20. Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250.
    Grabmaier K, Vissers JL, De Weijert MC, Oosterwijk-Wakka JC, Van Bokhoven A, Brakenhoff RH, Noessner E, Mulders PA, Merkx G, Figdor CG, Adema GJ, Oosterwijk E.
    Int J Cancer; 2000 Mar 15; 85(6):865-70. PubMed ID: 10709109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.